Loading patent…
OwnerAnson ABRAHAM, Helene FAESSEL +12inventors
InventorsAnson ABRAHAM, Helene FAESSEL, Yaming HANG, Brian HAREL, Marta KARAS, Haruhide KIMURA, Elena KOUNDOURAKIS, Tina OLSSON, Christian VON HEHN, Sebastian Philipp VON ROSENSTIEL, Vikram SINHA, Dmitri VOLFSON, Hao WANG, Andy ZHU
Estimating the term…
Disclosed herein are methods, uses and composition for treating narcolepsy with cataplexy (narcolepsy type 1 or NT1), blunted nocturnal blood pressure dip in a subject having narcolepsy type 1 or cognitive impairment in a subject having narcolepsy type 1, by administering an orexin receptor 2 agonist to the subject at one or more daily dosages.
A method of treating narcolepsy type 1 (NT1), the method comprising administering to a subject in need thereof about 1 mg to about 7 mg of Compound A:
A method of treating blunted nocturnal blood pressure (BP) dip in a subject having narcolepsy type 1 (NT1), the method comprising administering to the subject about 1 mg to about 7 mg of Compound A:
A method of treating cognitive impairment in a subject having narcolepsy type 1 (NT1), the method comprising administering to the subject about 1 mg to about 7 mg of Compound A:
-11. (canceled)
-23. (canceled)
-27. (canceled)
-41. (canceled)
(canceled)
-47. (canceled)
Dependencies are inferred from the claim text.